ADAMTS13 and thrombotic thrombocytopenic purpura: The inconsistency between the decrease in ADAMTS-13 levels and presence of inhibiting antibodies may explain the therapeutic effect of plasma infusion without exchange therapy in HIV-related TTP [13].